Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis

F Zepp1, M Knuf, P Habermehl

  • 1Pediatric Immunology and Infectious Diseases, Children's Hospital, Johannes Gutenberg University of Mainz, Germany. zepp@mzdmza.zdv.uni-mainz.de

Infection and Immunity
|October 1, 1996
PubMed

Insights

This study shows that infant pertussis vaccination with a tricomponent acellular vaccine generates lasting cell-mediated immunity. These T-cell responses remain stable, unlike antibody levels, suggesting a role in sustained protection.

Area of Science:

  • Immunology
  • Vaccinology
  • Pediatric Infectious Diseases

Background:

  • Pertussis (whooping cough) remains a concern despite vaccination.
  • Understanding cell-mediated immunity post-vaccination is crucial for assessing protection duration.
  • Acellular pertussis vaccines are widely used, necessitating research into their immunological impact.

Purpose of the Study:

  • To investigate pertussis-specific cell-mediated immunity in infants receiving a tricomponent acellular vaccine.
  • To analyze immune responses during primary vaccination and after a booster dose.
  • To characterize T-cell responses and cytokine profiles in infants under 12 months.

Main Methods:

  • Infants were monitored during primary vaccination (3-6 months) and pre/post-booster (15-24 months).
  • T-cell responses to vaccine antigens (detoxified pertussis toxin, filamentous hemagglutinin, pertactin) were assessed.
  • Activation marker expression (CD45RO) and cytokine secretion (IL-2, IFN-γ, IL-10) were measured.

Main Results:

  • The vaccine induced progressive T-cell responses specific to pertussis antigens.
  • Cell-mediated immunity remained stable between primary vaccination and booster doses, contrasting with declining antibody titers.
  • Vaccination increased CD45RO+ T cells and promoted a T-helper 1 cytokine profile (IL-2, IFN-γ).

Conclusions:

  • Tricomponent acellular pertussis vaccines induce persistent cell-mediated immunity in infants.
  • Stable cell-mediated immune responses may contribute to the protective mechanisms of pertussis vaccination.
  • Further research is needed to understand the persistence of cell-mediated immunity and its role in vaccine efficacy over time.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Vaccinations01:51

Vaccinations

Overview
Special Features of Adaptive Immunity01:20

Special Features of Adaptive Immunity

The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Immunological Memory01:23

Immunological Memory

Immunological memory, a pivotal pillar of the adaptive immune system, is responsible for the body's ability to remember and respond more swiftly and effectively to previously encountered pathogens. This remarkable feature is what makes vaccines so effective in preventing diseases.
What is Immunological Memory?
Immunological memory is an integral function of the immune system that allows it to recognize and react more rapidly and effectively to pathogens previously encountered. This feature is...
Active versus Passive Immunity01:31

Active versus Passive Immunity

Immunity, along with the ability to limit pathogen growth to prevent significant body tissue damage, can be gained either by (1) actively developing an immune response within the individual after exposure to a pathogen or after getting vaccinated or (2) passively transferring immune components from an immune individual to one who is nonimmune. Both these forms of immunity can be found naturally and in medical practices.
Active Immunity
Active immunity refers to the resistance one develops...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...